Portal de Periódicos da CAPES

International consensus recommendations for anesthetic and intensive care management of lung transplantation. An EACTAIC, SCA, ISHLT, ESOT, ESTS, and AST approved document

2021; Elsevier BV; Volume: 40; Issue: 11 Linguagem: Inglês

10.1016/j.healun.2021.07.012

1557-3117

Nándor Marczin, Eric E. C. de Waal, Peter Hopkins, Michael S. Mulligan, A. Simón, Andrew Shaw, Dirk Van Raemdonck, Arne Neyrinck, Cynthia Gries, Lars Algotsson, László Szegedi, Vera von Dossow, Aidan Burrell, Paula Carmona, Donna Greenhalgh, Dominik Höchter, Bessie Kachulis, Christopher S. King, Marc Licker, David R. McIlroy, Priya Nair, Daniela Pasero, David Pilcher, Steffen Rex, David Royston, Peter Slinger, Franco Valenza, Chris Walker, Antonio Arcadipane, O. Bastien, Joseph A. Bekkers, Dominique Béttex, Francesca Caliandro, Erika Dal Checco, Robert D. Davis, Göran Dellgren, Andreas Espinoza, Marie Louise Felten, Paolo Feltracco, Marc Fischler, Linda Fitzgerald, Ana Flo Forner, Isabel Fragata, Ana González Román, Paul Harris, Matthias Hommel, Nicholas Lees, Morgan Le Guen, Marc Léone, Thierry Lepoivre, Carlo Marcucci, S. Martelli, Mireille Michel-Cherqui, Ulrich Molitoris, Philippe Montravers, R. Mosca, Barbora Pařízková, Mahesh Prabhu, Francesco Pugliese, Sanjeev Raman, Cristina Ramos, V. Marco Ranieri, María Isabel Real, Sven-Erik Ricksten, Ana González Román, Bertrand Rozec, Shiva Sale, Juan F. Sánchez, Johanna Schwarzenberger, Sema Turan, Kamen Valchanov, Vincent G. Valentine, Peter von Homeyer, Alain Vuylsteke, Thomas Weig, Iratxe Zarragoikoetxea, Sebastian Zenz, Pierre‐Emmanuel Falcoz, İlhan İnci, Andrew Roscoe, Mert Şentürk,

Renal Transplantation Outcomes and Treatments

For patients with end-stage lung disease, LTx remains the only therapeutic option toward better chance of survival as well as improved quality of life. According to the International Society for Heart and Lung Transplantation (ISHLT) Transplant Registry, the number of LTx procedures has been rising despite limitations in available and suitable donor lungs and in the face of persistent donor shortages.1 The modern era of LTx is characterized by increasing complexity of recipient candidates including those receiving bridging extracorporeal support, a trend toward acceptance of suboptimal or extended criteria donors, and increasingly complicated surgical strategies.